February 3, 2016 By

Download Article in PDF

I. A Onwuezobe1, R. A. Effiom[1]

[1]Department of Medical Microbiology and Parasitology, University of Uyo, Nigeria

Background: Group B Streptococcus (GBS) is one of the common microbial agents causing urogenital infections in women of reproductive age especially pregnant women; it is also a common cause of neonatal infections in the world. Objective: To determine the prevalence and associated risk factors of GBS colonisation in pregnant women in an Urban Hospital in Nigeria.
Methods: A prospective cross sectional study of 150 pregnant women conducted in an Urban Hospital in Uyo, Nigeria between May and October 2013. Vaginal and anorectal swabs were collected from each participant and processed using standard microbiological methods and cultured on CHROMagarTM Strep B medium. Questionnaires for data were also used. Results: The age range of the participants was between 18 to 44years. Only 2 out of the 150 pregnant women were GBS carriers. The 2 women (1.33%) were found to be anorectal carriers, although 1 (0.67%), in addition had vaginal GBS. There was a statistically significant association between GBS colonisation and premature rupture of amniotic membranes (P<0.05). However, there was no association between GBS colonisation and risk factors such as age and gravidity.
Conclusions: Group B Streptococcus colonisation in pregnant women in Uyo, Nigeria, is associated with premature rupture of amniotic membrane.

Keywords: Group B Streptococcus, urogenital infections, colonisation, antenatal care, associated risk factors.

Group B Streptococcus (GBS) was first described as a cause of human infection in 1938. Since then, it has been implicated as the cause of illness in newborn babies, pregnant women and adults with other illnesses, such as diabetes or liver diseases. There are 15% to 40% of adult women colonised with Streptococcus agalactiae in the vaginal region, the neonates of the women may be infected after exposure to this bacterium before or during neonatal period[1]. About half of the cases of GBS among newborns happen in the first week of life (early-onset disease), and most of these cases start within a few hours after birth leading to sepsis, pneumonia, shock, stillbirth and perinatal mortality of 10% to 20%. Late-onset disease occurs from 7 to 90 days after birth and manifest primarily as meningitis. The recognition that maternal colonisation with the organism is a key factor in the occurrence of GBS-associated illnesses and mortality was a milestone in the history of perinatal health.
Different studies have reported that risk-based or screening-based strategies recommended by the Centres for Disease Control and Prevention (CDC) had caused a significant decline in the prevalence of neonatal GBS infections[2]. When public health decisions for implementing prevention strategies are needed, a basic point is the knowledge of prevalence of maternal GBS colonisation.
In Nigeria, this prevalence varies widely between geographic areas and even between different populations. For instance, it was reported a maternal colonisation rate of 1.8% in Ibadan[4], 3.6% in Jos[5], 11.3% in Ile-Ife[6] and 14% in Zaria.
Saint Luke’s Hospital is a public health institution that serves primarily the uninsured residents of Anua and neighbouring environs- constituting important regions in Uyo. Although Saint Luke’s hospital accounts for more than 90% of births in this area, no data are available about the prevalence of maternal GBS carriers.
Also in Uyo, Nigeria, the spectrum of group B Streptococcal disease remains a largely under-recognised problem and no guidelines have been formulated till now to curb its menace and screening is not routinely practiced due to the concentration of attention on HIV/AIDS in pregnant women and attendant consequences on neonates.
The present study was undertaken to find the prevalence of GBS in pregnant women and its relation to risk factors with the view of providing an epidemiological baseline data for policy formulators.

A four month cross-sectional prospective study was carried out in 150 parturient women admitted at Saint Lukes’ hospital, Anua after meeting the selection criteria having obtained ethical approval from the Human Research Ethics Committee (HREC), located at the Ministry of Health, Akwa Ibom State Secretariat, Uyo. The sample size of 150 was derived on the basis of women meeting the inclusion criteria. The inclusion criteria were all consenting pregnant women in their 35 to 37 weeks of gestation and not on any antibiotic treatment. The primary objective was to note the prevalence of GBS, and the secondary objective was to assess the risk factors associated with GBS colonisation.
Two swab samples were taken from the lower one third of the vagina and anal regions using sterile cotton swabs by the attending gynaecologist. These were transported to the medical microbiology laboratory of the University of Uyo Teaching Hospital in Amies transport medium (oxoid, UK) from where they were directly inoculated onto the surface of CHROMagarTM  Strep B medium containing supplements and incubated at 37oC for 18 to 24 hours under aerobic conditions. All colonies appearing with a mauve coloration suggestive of GBS were identified using standard microbiological techniques (Gram’s staining, catalase test and CAMP test). Colonies positive to CAMP test were further confirmed using Streptococcal grouping reagent B (oxoid, UK). Detailed information on socio-demographic characteristics of the women like age, occupation, ethnicity and educational attainment was noted by means of a standard questionnaire. Also, risk factors (previous maternal colonisation, gravidity, contraception use, gestational diabetes and premature rupture of amniotic membranes) were noted. Analysis was done using Statistical Package for Social Sciences (SPSS) VERSION 16. All statistical comparisons were done using chi-square analysis. Probability values less than 0.05 were considered as statistically significant.




A total of 150 pregnant women were screened for GBS out of which 104 were multigravids and 46 were primigravids. However, GBS was isolated in 2 (1.92%) multigravid women (Table 1). Two out of the 150 women (1.33%) were colonised in the anorectum and only 1 (0.67%) was colonised in the vagina (Figure 1). The age range of this pregnant population was between 18 to 44 years (mean age of 31 years) where the maximum number of pregnant women was in the age group of 21 to 30 years but the proportion of women with GBS carriage was highest in the age group of 31 to 44 years (2.44%) (Table 1). As regards the educational attainment of the women, rectovaginal colonisation was higher (3.23%) in women with higher educational attainment (Dip/NCE and HND/BSc.) than in those without higher education (FSLC and SSCE) (Table 2). On occupation, rectovaginal carriage was higher (1.75%) among women who were unemployed and students than those employed (1.08%) and this was statistically significant (Table 3).
Non-diabetic women were found to have rectovaginal colonisation (2 (1.33%)) when compared with the diabetic women who were found to have none (Table 4). Previous GBS colonisation was not associated with current GBS colonisation and rectovaginal colonisation of GBS was higher (2.33%) in women with history of contraception use than (0.93%) in those without (Table 4). The percentage of women with premature rupture of amniotic membranes and GBS colonization (25%) was found to be statistically significant when compared to women without premature rupture of membrane (0.68%) as shown in Table5.

Group B Streptococcus is one of the common microbial agents causing urogenital infections in women of reproductive age group especially pregnant women and also a cause of neonatal infections globally.[7] The infection by this microorganism may lead to urinary tract infection (UTI), bacteremia, and endometritis in women of reproductive age group. In pregnancy, it can cause UTI, endometritis, amnionitis, post-partum wound infections and neonatal complications such as prematurity, preterm labour, GBS pneumonia and meningitis[7,8].
Only 2 samples out of the 150 samples yielded the growth of GBS which accounted for a prevalence rate of 1.33%. Although it is comparable to 1.62% and1.8% gotten from studies done in India, Maputo and Mozambique respectively[9-14] it is however lower when compared with the report of findings in other parts of Nigeria like 9% in Calabar[15] 8.5% in Ibadan5 11.3% in Ile-Ife6 14% in Zaria[16] and 11% in Abeokuta.[17] This might be due to the more specific nature of the medium used.[18]
The premature rupture of amniotic membranes was the only risk factor significantly associated with current GBS colonisation. This risk factor could be used as a preliminary diagnostic marker for GBS colonisation as neonates born to these mothers may be at a greater risk of neonatal and infant disease. This observation was also in accordance with studies done in other countries.[19,20]
This study also corroborated the results of some studies[21,22] which showed increased GBS colonisation in multigravidity. It was found that women were more often colonised with GBS if they had been pregnant before (1.92%). This perhaps may be due to the likelihood of these multigravida women been exposed to multiple sexual partners thereby exposing them more to this organism and the likelihood of the primigravida maintaining a monogamous long term partnerships therefore and hence less likely to be exposed to this organism.
The pregnancy history or reproductive history, including the use of contraception during or prior pregnancy and recurrent gestational diabetes during pregnancy may be potential risk factors associated with GBS colonisation.[23-28] However no woman admitted having gestational diabetes and as such no inference could be made regarding recurrent gestational diabetes as a potential risk factor associated with GBS colonisation. This however may not be unrelated to health education especially preventive measure against excess weight during their antenatal visits. The lower colonisation rate (0.93%), amongst women using no method of contraception when compared to the higher rate (2.33%) in women using contraceptive may be attributed to the fact that women trying to achieve pregnancy are more likely to stick to one partner compared to women using contraception.

The prevalence rate of Group B Streptococcus colonisation is lower in Uyo when compared to some other cities in Nigeria. However premature rupture of amniotic membrane is a significant associated risk factor with this colonisation which may be used as a preliminary diagnostic marker for GBS colonisation in pregnant women.


  1. Lindahl G., Stalhammar-Carlemalm M., Areshong, T. Surface Proteins of    Streptococcus agalactiae and Related Proteins in other Bacterial Pathogens. Clinical Microbiology Review. 2005; 18: 102-127.
  2. CDC. Prevention of perinatal group B Streptococcal Disease: A Public Health Perspective. Morbidity and Mortality Weekly Report. 1996; 45: 1-24.
  3. Schuchat, A., Hilger, T. and Zell, E. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Emerg Infect Dis. 2001; 7:92-9.
  4. Olanisebe S. B., Adetosoye A. I. Determination of Asymptomatic Carrier Rate of Beta-haemolytic Group B Streptococcus in Vaginas of Pregnant Women in Ibadan, Nigeria. Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 261(2): 248-253.
  5. Nsagha D. S., Kamga H. L. F.,  Assob J. C. N., Njuda A. L., Bello C. S. S., Kandakai-Olukemi Y. T. Epidemiological Significance of the Colonisation of Streptococcus agalactiae in the Anorectum and Endocervix of Non-parturients in Jos, Nigeria. African Journal of Clinical and Experimental Microbiology. 2012; 13(3): 144-149.
  6. Onipede A., Adefusi O., Adeyemi A., Adejuyigbe E., Oyelese A., Ogunniyi, T. Group B Streptococcal Carriage During Late Pregnancy in Ile-Ife, Nigeria. African Journal of Clinical and Experimental Microbiology. 2012; 13(3): 135-143.
  7. Hyde T. B., Hilger T. M., Reingold A. Trends in incidence and antimicrobial resistance of early onset sepsis: population-based surveillance in San Francisco and Atlanta. Journal Paediatrics. 2002; 110 (4): 690-95.
  8. Schuchat A., Oxtoby M., Cochi S.  Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. Journal of Infectious Diseases. 1990; 162 (2): 672-677.
  9. Mhaskar R., Sathyan S., Shamsundar R., Nadig S., Bhat S. Selective Risk Factor-based Screening of Pregnant Women for Group B Streptococcal Colonization in a Teaching Hospital in South India. Indian Journal of Obstetrics and Gynecology. 2005; 55(4): 336-338.
  10. Nandyal R. R. Update on Group B Streptococcal infections. J periant Neonatal Nurs. 2008; 22: 230-37.
  11. Enweronu-Laryea C. C., Damale N. R. K., Newman M. J. Prevalence of Group B Streptococcus in Pregnant Women Attending a Tertiary Hospital in Ghana in 2001. Archives of Clinical Microbiology. 2011; 2(2): 5.
  12. Suara R. O.,  Adegbola R. A., Baker C. J., Secka O., Mulholland E. K., Greenwood B. M. Carriage of group B Streptococci in pregnant Gambian mothers and their infants. J Infect Dis.1994; 170 (5): 1316-9.
  13. Joachim A., Matee M. I., Massawe F. A. Lyamuya E. F. Maternal. Neonatal Colonisation of Group B Streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: Prevalence, Risk Factors and Antimicrobial Resistance. Journal of Biomedical Central Public Health. 2009; 9: 437.
  14. De Steenwinkel D. O., Tak H. U., Muller A. E., Nouwen J. L., Oostvogel P. M., Mocumbi S. M. Low Carriage Rate of Group B Streptococcus in Pregnant Women in Maputo, Mozambique. Tropical Medicine and International Health,. 2008; 13: 427- 429.
  15. Nwachukwu N. C., Utsalo S. J., Kanu I., Anyanwu E. C. Genital Colonisation of Group B Streptococcus at Term Pregnancy in Calabar, Nigeria. The Internet Journal of Paediatrics and Neonatology. 2007; 7: 9.
  16. Uhiara J. E. Group B Streptococcal Carriage among Parturient and Their Neonates in Zaria  Nigeria. African Journal of Medical Sciences. 1993; 22(3): 79-83.
  17. Hoppe J. E., Lindenau C., Hofler W. Rapid Detection of Group B Streptococci in Vaginal Swabs of Parturients by Latex Particle Agglutination. Zentralbl Bakteriol Mikrobiol Hyg A. 1989; 270(3): 379-384.
  18. Kwatra G., Madhi S. A., Cutland C. L., Buchmann E. J., Adrian P. V. Comparison of Chromagar Strep B, Columbia CNA and Lim Broth for the Isolation of Group B Streptococcus from Vaginal and Rectal Swabs from South Africa. Journal of Diagnostic Microbiology Method- Non-molecular. 2012; 12: 30.
  19. Bobitt J. R., Damato J. D., Sakakini J.  Perinatal Complications in Group B Streptococcal Carriers. A Longitudinal Study of Prenatal Patients. American Journal of Obstetrics and Gynecology. 1985; 151: 711-717.
  20. Patil K. P., Singla S. S., Nagmoti M. B., Swamy M. K. Group B Streptococci Colonisation in Pregnant Women: Is screening necessary? Journal of South Asian Federation of Obstetrics and Gynecology. 2013; 5(2): 64-67.
  21. Jeffery H. E., Royal P. A. H. Prevention and Treatment of Early-onset Group B Streptococcal Disease (EOGBSD) in Neonates. Paediatrics. 2002; 101: 2.
  22. Towers C. V., Suriano K., Asrat T. The Capture rate of at Risk Term Newborns for Early-onset Group B Streptococcal Sepsis Determined by Risk Factor Approach. American Journal of Obstetrics and Gynecology. 1999; 181: 1243-1249.
  23. Ramos E., Gaudier F. L., Hearing L. R., Del Valle G. O., Jenkins S., Briones D. Group B Streptococcus Colonisation in Pregnant Diabetic Women. Obstetrics and Gynecolology. 1997; 89: 257-260.
  24. Moghaddam M. N. Rectovaginal Colonisation of Group B Streptococcus in Pregnant Women Referred to a Hospital in Iran and Its Effects on Lactobacillus Normal Flora. Journal of Biological Sciences. 2010; 10: 166-169.
  25. Baker C. J., Kasper D. L. Immunological Investigation of Infants with Septicaemia or Meningitis Due to Group B Streptococcus. Journal of Infectious Diseases. 1977; 136: 98-104.
  26. Regan J. A., Klebanoff M. A., Nugent R. P. The epidemiology of Group B Streptococcal Colonisation in Pregnancy. Vaginal Infections and Prematurity Study Group. Journal of Obstetrics and Gynecology. 1991; 77: 604-610.
  27. Adair C., Kowalsky L., Quon H. Ma D., Stoffman, J., McGeer A., Robertson S., Mucenski, M. H.D.D. Risk Factors for Early-onset Group B Streptococcal Disease in Neonates: A Population-based Case-control Study. Canadian Medical Association Journal. 2003; 169: 193-203.
  28. Fletcher J. L., Gordon R. C. Perinatal Transmission of Bacterial Sexually Transmitted Diseases. Part II: Group B Streptococcus and Chlamydia trachomatis, Journal of Family Practise. 1990; 30: 689-696